Elacestrant dihydrochloride

CAS 1349723-93-8

Overview

Elacestrant dihydrochloride (sold as Orserdu) is an oral Selective Estrogen Receptor Degrader (SERD) approved to treat ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer. It is indicated for postmenopausal women and men whose disease progressed after endocrine therapy, acting by binding to and degrading estrogen receptors

Anant Labs manufacture and furnish high quality Elacestrant dihydrochloride impurities for global markets. Our Elacestrant dihydrochloride EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Elacestrant dihydrochloride

Cat. No. ANTPRD7826Old No. ANT-ELC-001CAS 1349723-93-8In Stock

Technical Data

New Cat. No.ANTPRD7826

Old Cat. No.ANT-ELC-001

CAS1349723-93-8

Mol. FormulaC₃₀H₄₀Cl₂N₂O₂

Mol. Weight531.56 g/mol

IUPAC(6R)-6-[2-[ethyl-[[4-[2-(ethylamino)ethyl]phenyl]methyl]amino]-4-methoxyphenyl]-5,6,7,8-tetrahydronaphthalen-2-ol;dihydrochloride

SMILESOC1=CC=C2C[C@H](C3=CC=C(OC)C=C3N(CC)CC4=CC=C(CCNCC)C=C4)CCC2=C1.[H]Cl.[H]Cl

InChIInChI=1S/C30H38N2O2.2ClH/c1-4-31-17-16-22-6-8-23(9-7-22)21-32(5-2)30-20-28(34-3)14-15-29(30)26-11-10-25-19-27(33)13-12-24(25)18-26;;/h6-9,12-15,19-20,26,31,33H,4-5,10-11,16-18,21H2,1-3H3;2*1H/t26-;;/m1../s1

InChI KeyXGFHYCAZOCBCRQ-FBHGDYMESA-N

Synonyms

(R)-6-(2-(Ethyl(4-(2-(ethylamino)ethyl)benzyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol dihydrochloride(6R)-6-{2-[ethyl({4-[2-(ethylamino)ethyl]phenyl}methyl)amino]-4-methoxyphenyl}-5,6,7,8-tetrahydronaphthalen-2-ol hydrochloride (1:2)(R)-6-[2-[Ethyl[4-(2-ethylaminoethyl)benzyl]amino]-4-methoxyphenyl]-5,6,7,8-tetrahydronaphthalen-2-ol DihydrochlorideElacestrant dihydrochloride1349723-93-8Elacestrant hydrochlorideRAD1901 dihydrochlorideRAD-1901 dihydrochloride8NZT0PR8AL2-Naphthalenol, 6-(2-(ethyl((4-(2-(ethylamino)ethyl)phenyl)methyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydro-, hydrochloride (1:2), (6R)-